Can iSpecimen Inc (ISPC) stock recover despite sales dropping?

In yesterday’s Wall Street session, iSpecimen Inc (NASDAQ:ISPC) shares traded at $0.29, down -9.92% from the previous session.

ISPC stock price is now 6.78% away from the 50-day moving average and -45.64% away from the 200-day moving average. The market capitalization of the company currently stands at $2.85M.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

In other news, Bielak Benjamin, Chief Info Officer & Secretary bought 18,000 shares of the company’s stock on Sep 14 ’23. The stock was bought for $12,960 at an average price of $0.72. Upon completion of the transaction, the Chief Info Officer & Secretary now directly owns 84,348 shares in the company, valued at $24460.92. An SEC document containing details of the transaction can be found on the SEC’s website. On May 31 ’23, CEO, CFO and Treasurer Curley Tracy bought 4,400 shares of the business’s stock. A total of $5,500 was incurred on buying the stock at an average price of $1.25. This leaves the insider owning 49,541 shares of the company worth $14366.89. A total of 41.24% of the company’s stock is owned by insiders.

During the past 12 months, iSpecimen Inc has had a low of $0.20 and a high of $1.75. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 0.93, and a quick ratio of 0.93. The fifty day moving average price for ISPC is $0.2644 and a two-hundred day moving average price translates $0.521015 for the stock.

The latest earnings results from iSpecimen Inc (NASDAQ: ISPC) was released for 2024-03-31. The net profit margin was -124.84% and return on equity was -92.94% for ISPC. The company reported revenue of $2.29 million for the quarter, compared to $2.95 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -22.37 percent.

Related Posts